Positron emission tomographic demonstration of myocardial oxidative metabolism in a case of left ventricular restoration after cardiac resynchronization therapy

Circulation Journal

Volumn 72, Issue 11, 2008, Pages 1900-1903

  Kitaizumi, Kenji ^a   Yukiiri, Kazushi ^a   Masugata, Hisashi ^a   Shinomiya, Kaori ^a   Ohara, Minako ^a   Takinami, Hiroyuki ^a   Iwado, Yasuyoshi ^a   Yoshida, Junji ^a   Noma, Takahisa ^a   Ohmori, Koji ^a   Yamashita, Yoichi ^a   Horii, Taiko ^a   Senda, Shoich ^a   Kohno, Masakazu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Cardiac resynchronization therapy; Left ventricular papillary muscle imbrication; Positron emission tomography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; CATECHOLAMINE; OXYGEN;

AEROBIC METABOLISM; AGED; ANAMNESIS; ARTICLE; BLOOD PRESSURE; BRAIN LEVEL; CARDIAC RESYNCHRONIZATION THERAPY; CASE REPORT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE; HEART MOVEMENT; HEART MUSCLE; HEART PAPILLARY MUSCLE; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE SEPTUM; HEART VENTRICLE TACHYCARDIA; HEART VENTRICLE WALL; HUMAN; HYPOKINESIA; LABORATORY TEST; MALE; MITRAL ANNULOPLASTY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; QRS COMPLEX;

AGED; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; HEART FAILURE; HUMANS; MALE; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; POSITRON-EMISSION TOMOGRAPHY; VENTRICULAR REMODELING;

EID: 55449132137     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-07-1011     Document Type: Article

References (9)

1. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
2. Higuchi K, Toyama T, Tada H, Naito S, Ohshima S, Kurabayashi M. Usefulness of biventricular pacing to improve cardiac symptoms, exercise capacity and sympathetic nerve activity in patients with moderate to severe chronic heart failure. Circ J 2006; 70: 703-709.
3. Inoue N, Takahashi N, Ishikawa T, Sumita S, Kobayashi T, Matsushita K, et al. Reverse perfusion-metabolism mismatch predicts good prognosis in patients undergoing cardiac resynchronization therapy: A pilot study. Circ J 2007; 71: 126-131.
4. Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH, et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delayed regional contraction after biventricular pacing therapy in heart failure. Circulation 2002; 105: 438-445.
5. Ukkonen H, Beanlands RS, Burwash IG, de Kemp RA, Nahmias C, Fallen E, et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation 2003; 107: 28-31.
6. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al; MIRACLE study Group; Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.
7. Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and narrow QRS. J Am Coll Cardiol 2003; 42: 2117-2124.
8. Leclercq C, Cazeau S, Le Breton H, Ritter P, Mabo P, Gras D, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998; 32: 1825-1831.
9. Kerwin WF, Botvinick EH, O'Connell JW, Merrick SH, DeMarco T, Chatterjee K, et al. Ventricular contraction abnormalities in dilated cardiomyopathy: Effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol 2000; 35: 1221-1227.